Iressa News and Research

RSS
Impact of a scientific presentation on community treatment patterns for primary breast cancer

Impact of a scientific presentation on community treatment patterns for primary breast cancer

Genzyme launches test to monitor Gleevec resistance

Genzyme launches test to monitor Gleevec resistance

Mutated oncogene triggers aggressive breast cancer

Mutated oncogene triggers aggressive breast cancer

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Gene mapping project promises new targeted cancer therapies

Gene mapping project promises new targeted cancer therapies

Researchers can now identify patients likely to respond to cancer drug therapy

Researchers can now identify patients likely to respond to cancer drug therapy

Mutations in the targets of designer drugs critically influence their effectiveness

Mutations in the targets of designer drugs critically influence their effectiveness

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Researchers discover sections of the chromosomes of lung cancer cells where cancer-related genes may lurk

Researchers discover sections of the chromosomes of lung cancer cells where cancer-related genes may lurk

DNA imaging suggests where lung cancer genes may reside

DNA imaging suggests where lung cancer genes may reside

FDA severely limits access to cancer drug Iressa

FDA severely limits access to cancer drug Iressa

AstraZeneca announces U.S. labeling change to Iressa (gefitinib tablets)

AstraZeneca announces U.S. labeling change to Iressa (gefitinib tablets)

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa

Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa

Clinical trial of gefitinib for advanced lung cancer closes early

Clinical trial of gefitinib for advanced lung cancer closes early

ViroLogic and AstraZeneca to conduct Iressa biomarker study

ViroLogic and AstraZeneca to conduct Iressa biomarker study